GettyImages-973074712

Patent Analytics Open Webinar

The Next Billion-Dollar Acquisition in Pharma. A Forward-looking Analysis of the Innovation Landscape of Tomorrow

To watch the recording, please submit the form below:

Watch the Recording

Presenters

Marco Richter
Marco Richter
COO
PatentSight
Gene Quinn
Gene Quinn
Patent Attorney, President & CEO
IPWatchdog
Kevin E. Noonan
Kevin E. Noonan
Biotechnology Patent Lawyer, Partner McDonnell Boehnen Hulbert & Berghoff

The Next Billion-Dollar Acquisition in Pharma. A Forward-looking Analysis of the Innovation Landscape of Tomorrow

Learn how the next billion-dollar acquisition will affect the innovation landscape in the pharmaceutical industry.

Join Gene Quinn, IPWatchdog.com and Marco Richter, LexisNexis PatentSight as they show you how the $74 billion deal between Bristol-Myers Squibb and Celgene may disrupt the crowded market for innovative cancer treatments.

What you will learn in this webinar:

  • how to spot acquisition targets
  • analyzing future scenarios of M&A
  • the impact of advanced patent analytics for due diligence evaluations
  • how to model divestiture scenarios and their effect on the technology landscape